Timothy Eugene Sullivan
Chief Financial Officer · Apellis Pharmaceuticals, Inc.
- 2025
- May 14, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Timothy Eugene Sullivan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Cedric Francois - $980K in APLS purchases and sales in the last 12 months
- David O. Watson - $697K in APLS purchases and sales in the last 12 months
- Nur Nicholson - $270K in APLS purchases and sales in the last 12 months
- Pascal Deschatelets - $198K in APLS purchases and sales in the last 12 months
- Caroline Baumal - $175K in APLS purchases and sales in the last 12 months
- Mark Jeffrey Delong - $147K in APLS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Timothy Eugene Sullivan?
Timothy Eugene Sullivan is a corporate insider, tracked as Chief Financial Officer of Apellis Pharmaceuticals, Inc. (APLS). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Timothy Eugene Sullivan last file a Form 4?
The most recent primary Form 4 on record is dated 14 May 2026, one of 8 filings going back to 2025.
Has Timothy Eugene Sullivan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($1.84M) across all tracked filings.
